Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models

INTRODUCTION: Multi-marker molecular assays have impacted management of early stage breast cancer, facilitating adjuvant chemotherapy decisions. We generated prognostic models that incorporate protein-based molecular markers and clinico-pathological variables to improve survival prediction. METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Parisi, Fabio, González, Ana M, Nadler, Yasmine, Camp, Robert L, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3096952/
https://ncbi.nlm.nih.gov/pubmed/20809974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2633
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky